Ovarian cancer progression is controlled by phenotypic changes in dendritic cells.

Abstract excerpt

We characterized the initiation and evolution of the immune response against a new inducible p53-dependent model of aggressive ovarian carcinoma that recapitulates the leukocyte infiltrates and cytokine milieu of advanced human tumors. Unlike other models that initiate tumors before the development of a mature immune system, we detect measurable anti-tumor immunity from very early stages, which is driven by...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Adaptive Immunity
• Share to Dendritic Cells